News
Pfizer's dividend yield is around 7.3%, which is super generous. If you have an opening in your portfolio for a great stock ...
CFO David Denton called the company’s commitment to its dividend "steadfast." As he has said in the past, Pfizer intends to ... stock's recent forward-looking price-to-earnings (P/E) ratio ...
The AI and data cloud Snowflake has announced enhanced warehouse features providing auto-tuning, more power, and more cost ...
Artificial intelligence trading tools that analyze reams of data and build portfolios are already shaking up Wall Street. But ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
With Main Street investors now able to trade as fast as some qualitative hedge funds, seismic changes could be ahead for the ...
In a report released yesterday, Vamil Divan from Guggenheim maintained a Buy rating on Savara (SVRA – Research Report), with a price target of $8.00. The company’s shares clos ...
(Bloomberg) -- Before the lawsuits started piling up in courtrooms across Connecticut, before his employer accused him of running a “massive Ponzi-like fraud,” and before the FBI showed up, Robert ...
As a consequence of Pfizer’s innovation, the price of citric acid tumbled over ... Pfizer seemed unable to allay the concerns of prime minister David Cameron and business secretary Vince Cable.
And with an eye to today’s Apple’s Worldwide Developers Conference, investors are hoping that technology stocks will help ...
In clinical trials, the tyrosine kinase inhibitor demonstrated a confirmed overall response rate of up to 90 percent and brain-penetrant efficacy.
Pfizer Inc. (NYSE:PFE ... drugmakers in the United States to revise their prices to align with the lowest price paid by similar high-income countries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results